Tag: Hatch-Waxman Act
Cost Comparison: Authorized Generics vs First-to-File Generics
Authorized generics and first-to-file generics differ in price, origin, and market impact. Authorized generics, made by brand companies, drive prices down faster than first-to-file generics alone, saving patients and the system money.
Read More
Generic Drug Availability: How Long After Patent Expiration Do They Actually Hit the Market?
Generic drugs don't appear immediately after patent expiration. Legal delays, patent thickets, and regulatory hurdles can push market launch out by years - costing patients billions. Here's how the system really works.
Read More
Hatch-Waxman Act: How It Created the Modern U.S. Generic Drug System
The Hatch-Waxman Act created the modern system for generic drug approval in the U.S., balancing innovation incentives with affordable access. It saved trillions but faces growing abuse.
Read More